Generics

Filter

Current filters:

None

Popular Filters

1 to 25 of 1149 results

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

03-03-2015

US generic drugmaker Mylan has reported strong growth throughout the company for the fourth quarter and…

FinancialGenericsMylanPharmaceutical sciencesUSA

Synthetic biology breakthrough leads to cheaper statin production

27-02-2015

University of Manchester researchers, together with industrial partner, Dutch biotech company DSM, have…

Cardio-vascularGenericsProduction

TWi Pharmaceuticals to use its own subsidiary in USA instead of Teva

24-02-2015

Generic drugmakers Taiwan-based TWi Pharmaceuticals and Israeli company Teva Pharmaceutical Industries…

GenericsLicensingLidodermMegace ESOncologyTeva Pharmaceutcal IndustriesTWi PharmaceuticalsUSA

Opportunities, challenges, strategies and forecasts for generic drugs market; report

Opportunities, challenges, strategies and forecasts for generic drugs market; report

23-02-2015

Already prevalent in the USA, Europe and much of the developing world, generic drugs are now finding…

BiosimilarsEuropeGenericsGlobalMarkets & Marketing

Actavis receives final FDA approval for generic version of Subutex

Actavis receives final FDA approval for generic version of Subutex

22-02-2015

Ireland-headquartered generics major Actavis has received final approval from the US Food and Drug Administration…

Abbreviated New Drug ApplicationGenericsIndiviorNeurologicalRC PharmaceuticalsReckitt BenckiserRegulationSubutexUSA

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Russian government may lift duties on imports of pharmaceutical substances

16-02-2015

The Russian government plans to provide subsidies for the production of pharmaceutical substances for…

GenericsMarkets & MarketingOncologyPoliticsProductionRussia

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis to sell its Pharmatech unit to TPG

13-02-2015

Ireland-headquartered generics major Actavis has reached a definitive agreement with TPG, the global…

ActavisAptalis PharmaGenericsMergers & AcquisitionsPharmatech

Julphar takes step into Bangladesh market with RAK Pharma acquisition

Julphar takes step into Bangladesh market with RAK Pharma acquisition

13-02-2015

Julphar, the largest Emirati pharmaceutical company, has acquired a majority stake in Bangladesh drugmaker…

BangladeshGenericsJulpharMergers & AcquisitionsRAK Pharmaceuticals

Hospira fourth-qtr 2014 earnings beat expectations

Hospira fourth-qtr 2014 earnings beat expectations

12-02-2015

US drugmaker Hospira, a leading provider of injectable drugs and infusion technologies, and a global…

FinancialGenericsHospiraPfizerUnited States

Breckenridge Pharma files ANDA for generic of Sanofi’s Jevtana

12-02-2015

Privately-held US generic drugmaker Breckenridge Pharmaceutical has filed an Abbreviated New Drug Application…

Breckenridge PharmaceuticalsGenericsJevtanaOncologyPatentsRegulationSanofiUSA

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

10-02-2015

US generics drugmaker Mylan has confirmed that it has been sued by German pharma major Bayer and partner…

BayerGenericsLegalMylanNexavarOncologyOnyx PharmaceuticalsPatentsPatents & Trade marksRegulationUSA

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

US FDA issues another warning letter over failures at Apotex’ Indian plant

US FDA issues another warning letter over failures at Apotex’ Indian plant

09-02-2015

The US Food and Drug Administration has issued yet another warning letter to Canada-headquartered generics…

ApotexApotex Research Private LimitedGenericsIndiaProductionRegulationUSA

Russian government may consider re-purchase from Abbott

09-02-2015

The Russian government may consider the possibility of the re-purchase of the Russian pharmaceutical…

AbbottGenericsMergers & AcquisitionsPoliticsRussiaVeropharm

India needs to reduce reliance on China for APIs

India needs to reduce reliance on China for APIs

08-02-2015

Stiff competition from China is undermining the Indian bulk drug industry. While imports from China are…

Antibiotics and Infectious diseasesChinaGenericsIndiaNeurologicalPoliticsProduction

Cambrex to invest $45-$50 million in API capacity expansion; posts strong financials

06-02-2015

US drugmaker Cambrex has initiated the second significant expansion of its Charles City, Iowa, facility…

CambrexFinancialGenericsProduction

1 to 25 of 1149 results

COMPANY SPOTLIGHT

Menarini

Back to top